Formulation and Evaluation of Nortriptyline Mucoadhesive Buccal Film Using Xanthan Gum for Smoking Cessation Therapy
International Journal of Innovative Science and Research Technology · 30.06.2026 · 1766
DOI: 10.38124/ijisrt/26jun964 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Innovative Science and Research Technology, online erschienen am 30.06.2026. Verfasst von S. Radhakrishnan und 7 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
Cigarette smoking continues to rank among the leading avoidable causes of mortality across the globe, responsible for millions of deaths every year. The persistence of nicotine dependence is driven mainly by two neurochemical pathways: activation of nicotinic acetylcholine receptors and glutamate-mediated signalling. Because nortriptyline, a tricyclic antidepressant, acts on several of the neurotransmitter systems tied to addiction, it has drawn interest as a smoking-cessation aid. A drawback of the conventional oral route, however, is that the drug is heavily metabolised on first pass through the liver, which sharply curtails how much reaches the circulation. This investigation therefore focused on preparing and assessing nortriptyline-loaded mucoadhesive buccal films. Two polysaccharides, xanthan gum and sodium alginate, served as the film-forming and mucoadhesive components, helping the film cling to the mucosa and regulating the rate at which the drug was liberated. The films were cast by solvent evaporation and then examined for appearance, thickness, weight consistency, folding endurance, surface pH, disintegration time, drug loading and release behaviour. Formulation variables were narrowed down with a design-of-experiments (DoE) scheme. Every batch proved uniform and mechanically sound, and the lead formulation maintained release for as long as 7 h. Of the five, batch F3 performed best, liberating close to 97% of its drug load while adhering most strongly to the mucosal surface.
Zitieren
APA
Radhakrishnan, S., Sambathkumar, R., Kannan, C., Hariprasath, R. K., Govindaraj, S., Vigneshwaran, R. H., Santhosh, C., & Vishnu, R. (2026). Formulation and Evaluation of Nortriptyline Mucoadhesive Buccal Film Using Xanthan Gum for Smoking Cessation Therapy. International Journal of Innovative Science and Research Technology, 1766. https://doi.org/10.38124/ijisrt/26jun964
Vancouver
Radhakrishnan S, Sambathkumar R, Kannan C, Hariprasath RK, Govindaraj S, Vigneshwaran RH, et al. Formulation and Evaluation of Nortriptyline Mucoadhesive Buccal Film Using Xanthan Gum for Smoking Cessation Therapy. International Journal of Innovative Science and Research Technology. 2026:1766. doi:10.38124/ijisrt/26jun964
BibTeX
@article{Radhakrishnan2026,
author = {Radhakrishnan, S. and Sambathkumar, R. and Kannan, C. and Hariprasath, R. K. and Govindaraj, S. and Vigneshwaran, R. Hari and Santhosh, C. and Vishnu, R.},
title = {Formulation and Evaluation of Nortriptyline Mucoadhesive Buccal Film Using Xanthan Gum for Smoking Cessation Therapy},
journal = {International Journal of Innovative Science and Research Technology},
year = {2026},
pages = {1766},
doi = {10.38124/ijisrt/26jun964}
}
EUVIMED